384 related articles for article (PubMed ID: 36845720)
1. Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors.
Cai H; Ren Y; Chen S; Wang Y; Chu L
Front Oncol; 2023; 13():1119369. PubMed ID: 36845720
[TBL] [Abstract][Full Text] [Related]
2. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
3. The crosstalk of CD8+ T cells and ferroptosis in cancer.
Lin Z; Zou S; Wen K
Front Immunol; 2023; 14():1255443. PubMed ID: 38288118
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
Gu X; Liu Y; Dai X; Yang YG; Zhang X
Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis and Cancer Immunotherapy.
Yin J; Meng X; Peng L; Xie W; Liu X; He W; Li S
Curr Mol Med; 2023; 23(5):401-409. PubMed ID: 35579155
[TBL] [Abstract][Full Text] [Related]
7. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy.
Zhou Z; Xu B; Hu N; Guo Z; Bao W; Shao B; Yang W
Front Biosci (Landmark Ed); 2022 Jun; 27(7):203. PubMed ID: 35866391
[TBL] [Abstract][Full Text] [Related]
9. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
10. Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes.
Gao Z; Zhang J; Hou Y; Lu J; Liang J; Gao Y; Li B; Gao S; Zhao Y; Gao M; Chen J
Biomaterials; 2024 Mar; 305():122442. PubMed ID: 38142469
[TBL] [Abstract][Full Text] [Related]
11. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
12. Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy.
Jiang Q; Wang K; Zhang X; Ouyang B; Liu H; Pang Z; Yang W
Small; 2020 Jun; 16(22):e2001704. PubMed ID: 32338436
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Tumor-Targeting Carbon Dots for Tumor Microenvironment Activated Ferroptosis and Immunotherapy in Cancer Treatment.
Bao Y; Li G; Li S; Zhang H; Wu X; Yan R; Wang Z; Guo C; Jin Y
ACS Appl Mater Interfaces; 2023 Nov; ():. PubMed ID: 38015563
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer.
Ding Q; Tang W; Li X; Ding Y; Chen X; Cao W; Wang X; Mo W; Su Z; Zhang Q; Guo H
J Control Release; 2023 Nov; 363():221-234. PubMed ID: 37717657
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
16. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis: Promising approach for cancer and cancer immunotherapy.
Zheng S; Guan XY
Cancer Lett; 2023 May; 561():216152. PubMed ID: 37023938
[TBL] [Abstract][Full Text] [Related]
18. Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
Liu L; Jin H; Dong M; Tian J; Li H; Liu Q; Chen Y; Zou Z
Apoptosis; 2022 Dec; 27(11-12):946-960. PubMed ID: 36028785
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Erythrocyte Membrane-Mimicking Fe
Yu K; Chen Y; Zhang L; Zheng Y; Chen J; Wang Z; Yu X; Song K; Dong Y; Xiong F; Dong Z; Zhu H; Sheng G; Zhu M; Yuan X; Guan H; Xiong J; Liu Y; Li F
ACS Appl Mater Interfaces; 2023 Sep; 15(38):44689-44710. PubMed ID: 37699536
[TBL] [Abstract][Full Text] [Related]
20. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
